Register for our S/EIS Fund

A passion for

measured risk

We are constantly innovating our people, project management and technology models leading to outstanding results for our collaborators. The world’s first app based technology platform Chemistry in the CloudTM enables us to work together to make faster decisions. Our deep understanding that an early and intensive evaluation of target molecules based on real insight into the science will lead to faster downstream execution. The result is a higher throughput of successful drug-like compounds.

Our in-house projects

Opal

Opal Oncology is a drug discovery company incorporated in 2012 and is based in Cambridge, UK. We have a vision for discovering and in-licensing small molecule cancer therapies.

Therapeutics news

News about theraputics coming soon.

@o2hventures

April 12th 2019 10:04:01

we are unable to follow anyone. Is it a bug from your end? I do not see my account has been suspended or blocked.… https://t.co/N7F4vnIs3M

@o2hventures

April 9th 2019 01:04:20

RT @BiotechJon: I note that o2h Therapeutics fund have announced participation in Exonate, Stemnovate and Metrion's recent financings. Cong…

@o2hventures

April 3rd 2019 03:04:34

We are proud to be a supporter for the T-20 Cricket in St. Kitts match between England and West Indies recently. At… https://t.co/7swGOf95Fs

@o2hventures

April 2nd 2019 12:04:07

Metrion Biosciences Closes Funding Round - o2h Ventures - https://t.co/g1P0VO5AvW

@Metrion_Biosci… https://t.co/Z9U8RPhsXb

@o2hventures

April 2nd 2019 12:04:14

We are pleased to welcome both o2h Ventures Therapeutics Fund as a new shareholder and Sunil Shah, Managing Partner… https://t.co/txSRsvEMta

@o2hventures

March 30th 2019 09:03:07

Delighted to attended Fragments 19 where o2h Discovery presented its proprietary fragment library that can help ide… https://t.co/qFEntuhp2l

@o2hventures

March 30th 2019 09:03:21

RT @Riddhi_16: @CygnetInfotech’s Dr. Nilesh Modi echoed the ethos ‘IT is about You’ at @O2hVentures #Innovation Conference quoting, @Andrew…

@o2hventures

March 29th 2019 01:03:11

The o2h Therapeutics and AI Fund makes investment in early stage biotechnology company @ExonateUK -… https://t.co/F4iV7xGuUl

@o2hventures

March 29th 2019 01:03:04

RT @GBIMagazine: o2h Ventures is raising a therapeutics fund to invest into early stage innovations with a view to license, or sell to larg…

@o2hventures

March 23rd 2019 12:03:50

Pleased to announce that o2h Discovery is attending and is a part-sponsor of the 7th RSC-BMCS Fragment-based Drug D… https://t.co/6ZMRWefaus